Ashok Soota commits Rs 200 Crore for SKAN Medical Research Trust for elderly people
Digital Edge Bureau 04 Apr, 2021 0 comment(s)In a new development, Ashok Soota, one of the torch bears of the Indian software caravan, has again shown his altruistic instincts. Yes, he has announced the creation of SKAN, an entity dedicated for medical research around elderly and neurologically afflicted people. He has also made a commitment of Rs 200 Crore for SKAN; wherein Rs 100 Crore is earmarked for partners such as St John’s, centre for brain research (CBR), IIT-Roorkee, NIMHANS and any new partners which may be added. While, the remaining Rs 100 Crore is spearheaded for investing in SKAN and other direct projects within SKAN.
Ashok Soota said, “it will take 10 years to build a world class institution for ageing and neurological research. I’m grateful to two eminent leaders who have agreed to take charge as chairpersons for the two divisions in case of an exigency to me if line leadership is not ready to take charge. I’ve had this exigency-based arrangement in every organization I started, be it MindTree or Happiest Minds”.
The research for the projects will be done through reputed partners, and directly in-house. The strategic partner for neurological research is the centre for brain research (CBR) at Indian institute science, Bangalore (IISc). The CBR is putting together a consortium to handle the first project on Parkinson’s disease. The strategic partner for Ageing is the upcoming St. John’s geriatric centre (SJGC), to be located on the St John’s Hospital campus. Soota has agreed to fund the setting up of the centre for research in ageing and geriatrics (CRAG) at the SJGC and to support joint projects. In Ageing, the approach will be to go wide into relatively under-researched areas and will include the establishment of a large community-based research cohort. For Neurological research, the plan will be to go deep into select areas like Parkinson’s disease, bipolar disorders, strokes and other cerebrovascular disorders.
For problems related to both ageing and neurological disorders, the philosophy of the research will include searching for kinder, gentler therapies; delaying the onset and slowing down the progression of diseases, and providing persons a better quality of life even as they live with the ailments.